We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics
Gold Supplier
Liquid Handling Workstation
AdvanSure E3 SYSTEM
Giardia, Cryptosporidium and E. Histolytica Antigen Test
SARS-CoV-2 Antigen Rapid Test
Flowflex SARS-CoV-2 Antigen Rapid Test (Nasal/Saliva)
Silver Supplier
Automated Nucleic Acid Extractor
Visit expo >

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
23 Sep 2021 - 25 Sep 2021


Image: The BD FACSLyric Flow Cytometry System (Photo courtesy of BD Diagnostics)

Encephalitis After Immunotherapy Detected Early by Blood Test

Immunotherapy is very effective for many cancers, but the treatment can also cause autoimmune side effects. Encephalitis is one of the most serious and difficult-to-diagnose side effects of immunotherapy. More...
16 Sep 2021
Image: The Invitrogen Qubit 4 Fluorometer is designed to accurately measure DNA, RNA, and protein quantity (Photo courtesy of Thermo Fisher Scientific)

Blood Testing Distinguishes Benign Tumors from Precancerous Condition

The leading cause of mortality for patients with the neurofibromatosis type 1 (NF1) cancer predisposition syndrome is the development of malignant peripheral nerve sheath tumor (MPNST), an aggressive soft tissue sarcoma. In the setting of NF1, this cancer type frequently arises from within its common and benign precursor, plexiform neurofibroma (PN). More...
15 Sep 2021
Image: The NanoQuant infinite M200 pro reader is an easy-to-use multimode plate reader family (Photo courtesy of Neotec Scientific Instrumentation)

CCN1 Analyzed as a Biomarker for Breast Cancer Detection

Breast cancer is the most frequent malignancy in women with 1.7 million new cases and over 500,000 deaths worldwide in 2016. Early detection of cancer is believed to be crucial in reducing cancer death. Despite recent progress in liquid biopsy technologies, early blood-based detection of breast cancer is still a challenge. More...
14 Sep 2021
Image: Schematic representation of cancer-related biomolecules such as cells, proteins, nucleic acids, miRNA and microvesicles circulating into the bloodstream, and collection of these biomarkers by liquid biopsy (Photo courtesy of University of Florence)

Liquid Biopsy Assay Evaluated for Early Detection of Gastric Cancer

Gastric cancer (GC) is the fourth most-commonly diagnosed cancer, and the third leading cause of cancer-associated mortality worldwide. Despite improvements in treatment modalities, the prognosis for advanced GC following curative resection remains poor. More...
08 Sep 2021
Image: The CellSearch Circulating Tumor Cell Kit is intended for the enumeration of circulating tumor cells of epithelial origin (CD45-, EpCAM+, and cytokeratins 8, 18+, and/or 19+ and PD-L1) in whole blood (Photo courtesy of CellSearch/Menarini Silicon Biosystems)

PD-L1 Expression in Circulating Tumor Cells Investigated for NSCLC

In non-small cell lung cancer (NSCLC), analysis of programmed cell death ligand 1 (PD-L1) expression in circulating tumor cells (CTCs) is a potential alternative to overcome the problems linked to the tumor biopsy spatiotemporal heterogeneity. However, the prognostic significance of PD-L1-positive [PD-L1(+)] CTCs remains controversial. More...
07 Sep 2021
Image: The NanoVelcro device has been used to detect placenta accreta spectrum (PAS) disorders (Photo courtesy of University of California, Los Angeles)

NanoVelcro Cell Technology Applied in Diagnosis of Pregnancy Complications

Placenta accreta spectrum (PAS) disorders, including placenta accreta, placenta increta, and placenta percreta, are the consequences of abnormal implantation, or aberrant invasion and adherence of placental trophoblasts into the uterine myometrium. More...
02 Sep 2021
Image: Blood film showing eosinophilic leukocytes (single cell arrowed) surrounded by red blood cells. About 50% of people with severe asthma may have elevated levels of eosinophils in their blood (Photo courtesy of Jane Liesveld, MD)

Exhaled Nitric Oxide and Eosinophil Count Diagnose Eosinophilic Asthma

Eosinophilic asthma is now recognized as an important subphenotype of asthma based on the pattern of inflammatory cellular infiltrate in the airway. Eosinophilic asthma can be associated with increased asthma severity, atopy, late-onset disease, and steroid refractoriness. More...
01 Sep 2021

The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
Copyright © 2000-2021 Globetech Media. All rights reserved.